Skip to content
AiViva BioPharma
  • Home
AiViva BioPharma
  • Home

Archive for October 2020

AiViva BioPharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer

By AiViva BioPharma | October 2, 2020
DNA strand

Novel Non-surgical Intradermal Treatment NEWPORT BEACH, Calif., October 2, 2020 (GLOBE NEWSWIRE) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun dosing patients diagnosed with superficial…

Read More

Recent Posts

  • Hannah Hershoff MD, PhD, has joined AiViva BioPharma as Chief Medical Officer
  • AiViva BioPharma Announces New Patent Received
  • AiViva BioPharma is recognized by Life Sciences Review as Top 20 Clinical-Stage Biopharmaceutical Company for 2022
  • AiViva BioPharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
  • AiViva BioPharma Announces Positive Data from Phase 1/2a Clinical Trial of AIV001 for Dermal Scarring and Wound Healing  

Recent Comments

No comments to show.

Archives

  • September 2022
  • August 2022
  • May 2022
  • October 2020
  • June 2020

Categories

  • Uncategorized
© 2023 AiViva BioPharma | Powered by Beaver Builder
Scroll To Top